According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are A$0.13 Billion. In 2023 the company made an earning of -A$27.9 Million, an increase over its 2022 earnings that were of -A$84.01 Million. The earnings displayed on this page is the company's Pretax Income.